Gut mucosal atrophy after a short enteral fasting period in critically ill patients

J Crit Care. 1999 Jun;14(2):73-7. doi: 10.1016/s0883-9441(99)90017-5.

Abstract

Purpose: The purpose of this study was to evaluate the presence of gut mucosal atrophy and changes in mucosal permeability in critically ill patients after a short fasting period.

Materials and methods: Fifteen critically ill patients underwent a period of enteral fasting of at least 4 days (mean 7.8 days). We took the following measurements the day before initiating enteral nutrition: indirect calorimetry, serum albumin, prealbumin, and lymphocyte count. We also performed a duodenal endoscopic biopsy with histopathological and mucosal morphometric analysis including villus height and crypt depth. The lactulose-mannitol test was performed to assess gut permeability. A total of 28 healthy volunteers served as controls for duodenal biopsy or lactulose-mannitol test. Clinical data, such as length of fasting, severity score, and previous parenteral nutritional support, were recorded.

Results: We found gut mucosal atrophy, expressed as a decrease in villus height and crypt depth, in patients compared with controls. The patients also exhibited an abnormal lactulose-mannitol test. Morphometric changes did not correlate with permeability. Further, we found no correlation between the results of the lactulose-mannitol test and of mucosal morphometry with clinical data.

Conclusions: We found that a short period of enteral fasting was associated with significant duodenal mucosal atrophy and abnormal gut permeability in critically ill patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Atrophy
  • Biopsy
  • Case-Control Studies
  • Cell Membrane Permeability
  • Critical Illness / therapy*
  • Duodenoscopy
  • Duodenum / pathology*
  • Fasting / adverse effects*
  • Female
  • Humans
  • Intestinal Mucosa / cytology
  • Intestinal Mucosa / pathology*
  • Intestinal Mucosa / physiopathology
  • Lactulose / pharmacokinetics
  • Lactulose / urine
  • Male
  • Mannitol / pharmacokinetics
  • Mannitol / urine
  • Middle Aged
  • Nutrition Assessment
  • Parenteral Nutrition, Total / adverse effects*
  • Time Factors

Substances

  • Mannitol
  • Lactulose